Skip to main content
. 2016 Oct 25;8(2):2130–2140. doi: 10.18632/oncotarget.12883

Figure 4. Comparison of the distribution of driver gene mutations identified in NSCLC tissue DNA (tDNA) and plasma DNA (ctDNA) samples.

Figure 4

(A) Mutation frequency of EGFR, KRAS, PIK3CA, ALK and RET in 39 sample pairs. (B) The number of mutation types (SNV, INDEL and gene fusion) detected in 39 paired samples.